Historically, this global pharmaceutical organisation had succeeded through first-to-market advantage or superior product offerings. But with the industry evolving, portfolios expanding, HCP expectations rising, and new competitors entering the field, they needed to retool how their customer-facing teams approached engagement.
It was no longer enough to rely on product strength. Sales teams needed a strategic mindset and differentiated skillset to compete effectively and ensure patients received the right medicines at the right time.
We partnered with the client to co-develop a global selling model that reframed competitive advantage around insight, agility, and execution.
The programme included:
All core materials – from frameworks to facilitator kits – were developed and delivered within three months. The programme has since been rolled out globally and is being embedded across field teams as the new standard for commercial engagement.
Internal champions praised the clarity and usability of the assets, noting how they made strategic selling more accessible and actionable for teams on the ground. By aligning everyone to a shared vision of competitive readiness, the model is helping reshape how the organisation approaches growth, differentiation, and customer value.
